The Role of Referred Pain From the Retro Trochanteric Region in Patients With Knee Pain

September 24, 2015 updated by: Oddmund Johansen, University Hospital of North Norway

The Role of Referred Pain From the Retro Trochanteric Region in Patients With Knee Pain. Prevalence, Interpretation and Management: A Randomized Controlled Study

The role of referred pain from the retro trochanteric region, in patients with knee pain. Defining and quantifying this sub group of knee patients in the investigators list of refered knee patients. Evaluating the effect of treatment. A randomized trial.

Study Overview

Status

Unknown

Conditions

Detailed Description

Knee pain is a great problem in the society. Besides obvious and known causes, for which there are increasing understanding and ways to treat, there is still a rather large group of patients in which the symptoms are not easily understood and harder to treat.

This group is often characterized by having symptoms ranging from months to years, having seen several physicians, gone through several x-rays/mri´s, and various treatment with no help.

The investigators find ever more suspicion towards specific mechanisms in the hip region as a source of knee pain. It is well known in pediatric medicine that children with serious disease in the hip often debut with knee pain. This relationship is not so well established in adults.

Pain in the lower extremity can arise from inflammation or strain of the retro trochanteric muscles, and/or more indirectly if these processes impact the sciatic nerve. The later explanation is commonly known as the piriformis syndrome.

Professor Oddmund Johansen has studied this type of pain extensively. In the later years he has found interest in patients with knee pain.

These patients will often have pain with deep palpation to the posterior hip region, when tightening the hip rotators with flexion and adduction, and they will often respond with pain relief, within minutes, when local anesthesia is placed on the distal attachment of the hip rotators on the posterior margin of the greater trochanter. Afterwards, lasting pain relief can be seen with a specified stretching regiment for these muscles.

The investigators will recruit suiting patients from a knee referral list. Inclusion will be based on clinical examination and whether they respond to the injection. After inclusion they will be scored with pain and quality of life forms, randomised in two groups, one with a stretching regime and one with conservative and symptomatic treatment.

There is interest in defining and quantifying this sub group of knee patients. They will be followed up after 3 months, with a new examination and scoring to evaluate the effect of the intervention.

The study will examine how the patients react and comply with the proposed diagnosis and treatment. A cost analysis will also be considered.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Tromsø, Norway
        • University Hospital of Northern Norway
        • Contact:
        • Contact:
        • Principal Investigator:
          • Anders Hennig, Physician
        • Sub-Investigator:
          • Oddmund Johansen, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Knee pain
  • Failure to understand the pain with more conventional diagnosis
  • Symptoms and retrotrochanteric pain with examination
  • Pain relief with retro trochanteric local anaesthetic injection

Exclusion Criteria:

  • Mental illness
  • Failure to cooperate
  • Not adequate Norwegian language skills
  • Other well known disease explaining symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Physiotherapy Group
Physiotherapy
Physiotherapy
Placebo Comparator: Conservative group
Conservative treatment
Conservative treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain on VAS score
Time Frame: At 3 months
0 no pain, 10 worst possible pain
At 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
KOOS score subscales Pain
Time Frame: At 3 months
Standard scoring on the KOOS subscale of pain
At 3 months
KOOS score subscale Symptoms
Time Frame: At 3 months
Standard scoring on the KOOS subscale of symptoms
At 3 months
KOOS score subscale Function in daily living
Time Frame: At 3 months
Standard scoring on the KOOS subscale of Function of daily living
At 3 months
KOOS score subscale Knee-Related Quality of Life
Time Frame: At 3 months
Standard scoring on the KOOS subscale of Knee-Related Quality of Life
At 3 months
KOOS score subscale Function in Sports and Recreation
Time Frame: At 3 months
Standard scoring on the KOOS subscale of Function in Sports and Recreation
At 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Working full time the last week
Time Frame: At 3months
Response yes or no to question if the participant worked full time last week
At 3months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Oddmund Johansen, Professor, University Hospital og North Nprway, ortopedic department

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Anticipated)

August 1, 2016

Study Completion (Anticipated)

August 1, 2017

Study Registration Dates

First Submitted

May 11, 2015

First Submitted That Met QC Criteria

September 24, 2015

First Posted (Estimate)

September 25, 2015

Study Record Updates

Last Update Posted (Estimate)

September 25, 2015

Last Update Submitted That Met QC Criteria

September 24, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2015/157(REK)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Referred Pain

Clinical Trials on Physiotherapy

3
Subscribe